Bluebirdbio stock.

Nov 24, 2023 · The low in the last 52 weeks of bluebird bio stock was 2.52. According to the current price, bluebird bio is 155.56% away from the 52-week low. What was the 52-week high for bluebird bio stock?

Bluebirdbio stock. Things To Know About Bluebirdbio stock.

In December, Bluebird Bio (BLUE 11.52%) and Structure Therapeutics (GPCR 6.97%) both have important events that could boost their stock prices in a big way. Here's what investors need to know ...Trading bluebird bio to $6: Bluebird bio (BLUE) is a biotech company focused on developing and commercializing gene and cell therapies to treat genetic diseases. Lead asset LentiGlobin (Zynteglo) is approved in US and Europe for the treatment of transfusion-dependent thalassemia. Bluebird's LentiGlobin (lovo-cel) is also in prBluebird bio (BLUE ...Bluebird bio stock price target cut to $86 from $172 at Evercore ISI. 0. Canada Goose downgraded to buy from strong buy at CFRA. 0. Canada Goose stock price target cut to $50 from $65 at CFRA. 0. Children's Place downgraded as e-commerce puts margins at …The past several years have been brutal for biotech company Bluebird bio (BLUE 1.34%).Shares of the gene-editing specialist are down by 85% since early 2020 as it has had to deal with clinical and ...Gene-therapy biotech Bluebird Bio's (BLUE-3.26%) stock price is down by 41% in the last 12 months, so it's no surprise that investors are wondering whether it's priced at a bargain.

Even Bluebird Bio (NASDAQ:BLUE) is waiting on a US FDA decision on its sickle cell treatment, lovo-cel. With a decision date set for Dec. 20 , BLUE is already gaining momentum, running from about ...Apr 6, 2023 · The case for buying the dip isn't exactly a slam dunk. With the stock down 52% in the last three months, Bluebird Bio ( BLUE -1.28%) shareholders are bound to be feeling pretty antsy. Between the ...

bluebird bio, Inc. Announces Pricing of $120 Million Public Offering of Common Stock. SOMERVILLE, Mass. -- (BUSINESS WIRE)--Jan. 18, 2023-- bluebird bio, Inc. (Nasdaq: BLUE) (“bluebird”) today announced the pricing of its underwritten public offering of 20,000,000 shares of its common stock at a public offering price of $6.00 per …Forward-looking statements in this press release should be evaluated together with the many risks and uncertainties that affect bluebird bio’s business, particularly those identified in the risk factors discussion in bluebird bio’s Annual Report on Form 10-K, as updated by our subsequent Quarterly Reports on Form 10-Q, Current Reports on ...

Bluebird Bio has a market capitalization of around $425 million at the moment, so this small-cap biotech stock could see a significant increase in its share price if it lands this historic approval.View the latest bluebird bio Inc. (BLUE) stock price, news, historical charts, analyst ratings and financial information from WSJ. In December, Bluebird Bio (BLUE 11.52%) and Structure Therapeutics (GPCR 6.97%) both have important events that could boost their stock prices in a big way. Here's what investors need to know ...November 04, 2021 07:00 AM Eastern Daylight Time. CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- bluebird bio, Inc. (NASDAQ: BLUE) today announced the company has completed the tax-free spin-off of its ...Discover historical prices for BLUE stock on Yahoo Finance. View daily, weekly or monthly format back to when bluebird bio, Inc. stock was issued.

We would like to show you a description here but the site won’t allow us.

Let's look at one biotech company Wall Street thinks could skyrocket: bluebird bio (BLUE 0.61%). This gene-editing specialist has an average price target of $6.64, according to Yahoo!

The U.S. Food and Drug Administration on Wednesday approved bluebird bio's gene therapy for patients with a rare disorder requiring regular blood transfusions, and the drugmaker priced it at a ...The bluebird bio stock price gained 3.74% on the last trading day (Thursday, 2nd Nov 2023), rising from $2.94 to $3.05. During the last trading day the stock fluctuated 7.02% from a day low at $2.92 to a day high of $3.13. The price has risen in 7 of the last 10 days and is up by 9.71% over the past 2 weeks. Volume has increased on the …Bluebird bio's blood disorder treatment demonstrates "clinically meaningful" benefit in patients, staff reviewers at the U.S. Food and Drug Administration said in briefing documents published on ...Aug 21, 2022 · The most important gene therapy for Bluebird is lovo cel, which has market size of 100k. If that gets approved (which will not happen before 2023), we should see a big spike in share price. They ... Bluebird Bio ( BLUE) is trending after the U.S. Food and Drug Administration (FDA) lifted its hold on the company’s sickle cell disease treatment. Bluebird Bio says it’s on track to submit a ...

Bluebird Bio has a market capitalization of around $425 million at the moment, so this small-cap biotech stock could see a significant increase in its share …bluebird bio, Inc., based in Somerville, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders. The company's only - in the European Union (EU) - approved drug is betibeglogene autotemcel (Zynteglo), which treats transfusion-dependent beta thalassemia (TDT), a rare genetic blood disorder, and has been approved for use by the European Medicines Agency.Aug 28, 2023 · Bluebird Bio (BLUE 11.52%), a leader in gene therapy, could be a great pick for growth investors.This company has two gene therapies that the U.S. Food and Drug Administration (FDA) has approved ... Summary. bluebird works as a biotech company developing curative gene therapies to save lives. Concerns over its cash runway and clinical trials are overblown, with the stock near all-time lows ...Latest news about bluebird bio, Inc. Wedbush Lowers bluebird bio's Price Target to $5 From $7, Maintains Neutral Rating. Nov. 08. MT. Transcript : Bluebird bio, Inc., Q3 2023 Earnings Call, Nov 07, 2023. Nov. 07. CI. Earnings Flash (BLUE) BLUEBIRD BIO Reports Q3 Revenue $12.4M, vs. Street Est of $13.4M. Nov. 07.Apr 15, 2022 · With its shares down by around 84% in the past year, it's a wonder that investors are still interested in Bluebird Bio ( BLUE -4.44%) at all. It withdrew its beta thalassemia drug, Zynteglo, from ...

Find the latest historical data for bluebird bio, Inc. Common Stock (BLUE) at Nasdaq.com.Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...

Investors are ditching this gene therapy stock en masse, for good reason. The share price of bluebird bio ( BLUE -0.91%) is down a staggering 70% over the past year. The company has encountered ...Get the latest bluebird bio, Inc. (BLUE) stock news and headlines to help you in your trading and investing decisions.According to 9 stock analysts, the average 12-month stock price forecast for bluebird bio stock is $7.91, which predicts an increase of 107.07%. The lowest target is $3.00 and the highest is $13. On average, analysts rate bluebird bio stock as a buy.SOMERVILLE, Mass.--(BUSINESS WIRE)--Aug. 8, 2023-- bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported financial results and business highlights for the second quarter ended June 30, 2023, including recent commercial and operational progress, and regulatory updates.On average, Wall Street analysts predict that Bluebird Bio's share price could reach $7.55 by Nov 8, 2024. The average Bluebird Bio stock price prediction ...The last 12 months haven't been kind to the likes of gene editing stocks like CRISPR Therapeutics (CRSP 2.88%) and Bluebird Bio (BLUE 11.52%). Whereas CRISPR's shares fell by 31%, Bluebird's are ...[relinking] Home History Owners Mission How It Works How It Makes Money A Brief History of bluebird bio, Inc. (BLUE) bluebird bio, Inc. is a biotechnology company that focuses on developing gene therapies for severe genetic diseases and cancer. The company was founded in 1992 by a group of former employees of Genzyme, a biotechnology company …Get the latest bluebird bio Inc (BLUE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Dec 1, 2023 · 12 analysts have issued 1-year price objectives for bluebird bio's shares. Their BLUE share price targets range from $3.00 to $13.00. On average, they expect the company's share price to reach $7.62 in the next twelve months. This suggests a possible upside of 95.9% from the stock's current price. bluebird bio, Inc. Announces Pricing of $120 Million Public Offering of Common Stock. (Business Wire) -17.24%. 09:12AM. Moderna Gets Good News, but Another Biotech Stock Is Falling Again.

bluebird bio, Inc. Common Stock (BLUE) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.

Item 1.01. Entry into a Material Definitive Agreement. On January 18, 2023, bluebird bio, Inc. entered into an underwriting agreement with Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC, as...

bluebird bio, Inc. (BLUE) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. As of 03:57PM EST. Market open. See bluebird bio, Inc. (BLUE) stock analyst estimates, including earnings and ... bluebird bio Submits Biologics License Application (BLA) to FDA for ...Mar 29, 2023 · SOMERVILLE, Mass., March 29, 2023--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported financial results and business highlights for the fourth quarter and full year ... bluebird bio Inc bluebird bio Inc BLUE Morningstar Rating Unlock Stock XNAS Rating as of Nov 29, 2023 Summary Chart News Price vs Fair Value …12 thg 7, 2023 ... Concerns over its cash runway and clinical trials are overblown, with the stock near all-time lows. ... bluebird bio's product pipeline (www.bluebird bio Inc bluebird bio Inc BLUE Morningstar Rating Unlock Stock XNAS Rating as of Nov 29, 2023 Summary Chart News Price vs Fair Value …bluebird bio Inc. Watch NEW Set a price target alert Open Last Updated: Nov 27, 2023 1:11 p.m. EST Real time quote $ 3.7650 -0.1250 -3.21% Previous Close $3.8900 Advanced Charting Volume: 2.77M... Jan 14, 2022 · What happened. Shares of gene therapy company Bluebird Bio ( BLUE -6.90%) fell by 10.7% through the first four full days of trading this week, according to data provided by S&P Global Market ...

Nov 26, 2023 · Target values for the price of one bluebird bio share for Nov 2025. The weighted average target price per bluebird bio share in Nov 2025 is: 8.72. In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 19.746% volatility is expected. Pessimistic target level: 7.95. Optimistic target level: 9.91. Find the latest bluebird bio, Inc. (BLUE) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.bluebird bio ( BLUE 0.52%) is a biotech company that specializes in gene editing, a technology that allows scientists to modify the genetic material of living organisms. Gene editing has the ...Instagram:https://instagram. 2022 extension deadlinerare chinese coinst rowe price small cap valuejanuary dividend stocks bluebird bio (BLUE) added ~8% pre-market Wednesday after Bank of America upgraded the stock, citing potential FDA approval for its SCD therapy lovo-cel. Read more here.Bluebird bio's blood disorder treatment demonstrates "clinically meaningful" benefit in patients, staff reviewers at the U.S. Food and Drug Administration said in briefing documents published on ... best online broker for penny stocksiridium communications stock Nov 24, 2023 · The low in the last 52 weeks of bluebird bio stock was 2.52. According to the current price, bluebird bio is 155.56% away from the 52-week low. What was the 52-week high for bluebird bio stock? nasdaq banf Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since its IPO on the Shenzhen stock exchange, its share price has...With that in mind, let's look at two relatively risky small-cap stocks that could be worthwhile investments if everything goes well: bluebird bio ( BLUE 1.93%) and Planet 13 Holdings ( PLNH.F 2.13 ...